Form 13-F position report

TELADOC HEALTH, INC.

Reported by Point72 Asset Management L P

TDOC CUSIP 87918A105 Manager CIK 0001603466

Reported 7,839,754 shares, up 1,329,852 (20.4%) from the prior quarter.

Reported value 31.8%; share count 20.4% vs. the prior quarter.

Added
% of reported 13F value 0.13% This manager · Q2 2025
Shares 7,839,754 Quarter-end amount reported
Reported value $68,284,256 Fair value at quarter end
Consecutive quarters held 10 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 1021000
2022-06-30 0
2023-03-31 425376
2023-06-30 25
2023-09-30 0
2023-12-31 31397617
2024-03-31 24880074
2024-06-30 51864541
2024-09-30 76802590
2024-12-31 101624953
2025-03-31 51818818
2025-06-30 68284256
2025-09-30 44550635
2025-12-31 39629254
2026-03-31 42082148
2026-06-30 69874581

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for TELADOC HEALTH, INC. held by Point72 Asset Management L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 8,239,927 +518,432 (6.7%) 0.08% $69,874,581 2026-08-14
Q1 2026 Added 7,721,495 +2,060,173 (36.4%) 0.05% $42,082,148 2026-05-15
Q4 2025 Reduced 5,661,322 -102,020 (-1.8%) 0.04% $39,629,254 2026-02-17
Q3 2025 Reduced 5,763,342 -2,076,412 (-26.5%) 0.07% $44,550,635 2025-11-14
Q2 2025 Added 7,839,754 +1,329,852 (20.4%) 0.13% $68,284,256 2025-08-14
Q1 2025 Reduced 6,509,902 -4,669,961 (-41.8%) 0.12% $51,818,818 2025-05-15
Q4 2024 Added 11,179,863 +2,813,568 (33.6%) 0.22% $101,624,953 2025-02-14
Q3 2024 Added 8,366,295 +3,063,172 (57.8%) 0.2% $76,802,590 2024-11-14
Q2 2024 Added 5,303,123 +3,655,436 (221.9%) 0.14% $51,864,541 2024-08-14
Q1 2024 Added 1,647,687 +190,721 (13.1%) 0.06% $24,880,074 2024-05-15
Q4 2023 New 1,456,966 +1,456,966 (0.0%) 0.08% $31,397,617 2024-02-14
Q3 2023 Reduced 0 -1 (-100.0%) 0 $0 2023-11-14
Q2 2023 Reduced 1 -16,423 (-100.0%) < 0.01% $25 2023-08-14
Q1 2023 New 16,424 +16,424 (0.0%) < 0.01% $425,376 2023-05-15
Q2 2022 Reduced 0 -14,161 (-100.0%) 0 $0 2022-08-15
Q1 2022 New 14,161 +14,161 (0.0%) < 0.01% $1,021,000 2022-05-16
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

432 managers reported TELADOC HEALTH, INC. for Q2 2025.

Managers reporting TELADOC HEALTH, INC. in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 21,019,218 +1,266,880 < 0.01% $183,077,389 40 qtrs
BlackRock Inc Reduced 13,834,713 -1,139,371 < 0.01% $120,500,349 4 qtrs
Point72 Asset Management L P This report Added 7,839,754 +1,329,852 0.13% $68,284,256 10 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 7,321,542 +775,300 0.08% $63,770,631 15 qtrs
DIMENSIONAL FUND ADVISORS LP Added 5,564,088 +512,978 0.01% $48,463,080 28 qtrs
STATE STREET CORPORATION Reduced 4,978,776 -35,006 < 0.01% $43,365,139 40 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 4,150,197 +84,356 < 0.01% $36,152,769 40 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 3,039,663 +448,324 < 0.01% $26,475,466 5 qtrs
TWO SIGMA ADVISERS LP Added 2,840,011 +5,600 0.05% $24,736,496 13 qtrs
Maple Rock Capital Partners Inc Reduced 2,688,278 -659,062 1.15% $23,414,901 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 14, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
7,839,754
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.